- Report
- January 2024
- 306 Pages
Global
€4767EUR$4,995USD£3,994GBP
- Report
- January 2022
- 275 Pages
Global
From €3436EUR$3,600USD£2,879GBP
- Report
- January 2024
Global
From €3436EUR$3,600USD£2,879GBP
- Report
- April 2023
- 91 Pages
Global
From €3500EUR$3,929USD£3,035GBP
- Report
- June 2023
- 286 Pages
Global
From €3407EUR$3,570USD£2,855GBP
The Viral Vector Manufacturing market is a subset of the genomics industry that focuses on the production of viral vectors for gene therapy. Viral vectors are modified viruses that are used to deliver genetic material into cells, allowing for the expression of a desired gene. This technology has been used to treat a variety of diseases, including cancer, cystic fibrosis, and hemophilia.
The Viral Vector Manufacturing market is highly competitive, with a number of companies offering a range of services. These services include vector design, vector production, and vector characterization. Companies also provide custom services to meet the specific needs of their customers.
Some of the major players in the Viral Vector Manufacturing market include Lonza, Thermo Fisher Scientific, Merck KGaA, and Oxford BioMedica. These companies offer a range of services, from vector design to vector production and characterization. Show Less Read more